FDA approves palbociclib with letrozole for advanced postmenopausal breast cancer
03/02/2015 - 23:53
Palbociclib, a cyclin-dependent kinase 4/6 inhibitor, has been approved by the Food and Drug Administration for treating postmenopausal women with est... More »
